A carregar...
Atezolizumab for the treatment of non-small cell lung cancer
INTRODUCTION: The immune system can restrain or promote cancer development and growth. Antibodies targeting immune checkpoints have revolutionized cancer treatment. Among the best responses have been in non-small cell lung cancer (NSCLC) which is largely caused by chronic exposure to carcinogens; as...
Na minha lista:
| Publicado no: | Expert Rev Clin Pharmacol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6089509/ https://ncbi.nlm.nih.gov/pubmed/28714780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17512433.2017.1356717 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|